Combination of tolerogenic peptides and TFG-B for use in the induction and maintenance of oral tolerance in young mammals

US10478472B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10478472-B2
Application numberUS-201615580180-A
CountryUS
Kind codeB2
Filing dateJun 10, 2016
Priority dateJun 12, 2015
Publication dateNov 19, 2019
Grant dateNov 19, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This invention relates to the administration of a combination of TGF-β and one or more peptides comprising specific sequences of β-lacto-globulin. The peptides are hypoallergenic but retain the capability to induce tolerance to the native protein. The combination of TGF-β and one or more of these peptides has the therapeutic effect of inducing and maintaining oral tolerance towards newly introduced proteins, in particular, at the weaning period. The combination can modulate the infant and toddler immune response to allergens.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for induction and maintenance of oral tolerance to β-lactoglobulin (BLG) and maintenance of oral tolerance to other food proteins that has been acquired via consumption of maternal mill in a young mammal during and after weaning period, the method comprising administering to the young mammal a composition comprising at least eight different peptides; each having a length from five to twelve amino adds that comprises a sequence selected from SEQ ID No. 1-8, and the composition further comprising transforming growth factor-beta (TGF-β), wherein each of SEQ ID NOs: 1-8 is present in the composition. 2. A method for primary prevention of allergic reactions to milk proteins and to electedly introduced dietary protein in a young mammal during and after weaning, the method comprising administering to the young mammal a composition comprising at least eight different peptides, each having a length from five to twelve amino adds that comprises a sequence selected from SEQ ID No. 1-8, and the composition further comprising TGF-β-β), wherein each of SEQ NOs: 1-8 is present in the composition. 3. The method according to claim 1 , wherein the young mammal is a human infant or toddler. 4. The method according to claim 1 , wherein the young mammal has been fed maternal milk from a mother who has been exposed to an ingredient selected from the group consisting of milk, egg, nut, peanut, shellfish, wheat, soy, and any other food protein during the feeding period. 5. The method according to claim 1 , wherein the young mammal is at risk of developing allergy. 6. The method according to claim 1 , wherein the young mammal is a companion animal. 7. The method according to claim 2 , wherein the young mammal is a human infant or toddler. 8. The method according to claim 2 , wherein the young mammal has been fed maternal milk from a mother who has been exposed to an ingredient selected from the group consisting of milk, egg, nut, peanut, shellfish, wheat, soy, and any other food protein during the feeding period. 9. The method according to claim 2 , wherein the young mammal is at risk of developing allergy. 10. The method according to claim 2 , wherein the young mammal is a companion animal.

Assignees

Inventors

Classifications

  • for weanlings · CPC title

  • A23L33/17Primary

    Amino acids, peptides or proteins · CPC title

  • A23K20/147Primary

    Polymeric derivatives, e.g. peptides or proteins · CPC title

  • Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title

  • Peptides; Protein hydrolysates · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10478472B2 cover?
This invention relates to the administration of a combination of TGF-β and one or more peptides comprising specific sequences of β-lacto-globulin. The peptides are hypoallergenic but retain the capability to induce tolerance to the native protein. The combination of TGF-β and one or more of these peptides has the therapeutic effect of inducing and maintaining oral tolerance towards newly introd…
Who is the assignee on this patent?
Nestec Sa, Nestle Sa
What technology area does this patent fall under?
Primary CPC classification A23L33/17. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Nov 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).